Ethyreal Bio manifests with $101M in pack of biotechs gunning for Amgen’s Tepezza

Ethyreal Bio manifests with $101M in pack of biotechs gunning for Amgen’s Tepezza is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Nick Paul Taylor · 2026-06-10

Ethyreal Bio has exited stealth with $101 million, joining the queue of companies preparing to challenge Amgen’s Tepezza.

Source: FierceBiotech